Race for coronavirus treatment

Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.

The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.

The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.

It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.

The trial is due to start next week.

Last local news

Evening Update Friday 18 September 2020

The Prefect of the Alpes Maritimes announced new measures today to combat the spread of covid-19 in Nice. ... Evening Update Friday 18 September 2020 Read More

18/09/2020

Lunchtime News Friday 18th September 2020

The president of the “Citizens” association David Nakache, has criticized loudspeakers in Nice broadcasting anti-Covid-19 prevention messages saying “... Lunchtime News Friday 18th September 2020 Read More

18/09/2020

French and Riviera News Friday 18th September 2020

A man has died following a diving accident in Cavalaire-sur-Mer in the Var. The accident occurred at a popular site for divers in the region.... French and Riviera News Friday 18th September 2020 Read More

18/09/2020

Evening Update Thursday 17 September 2020

French Minister of Health Olivier Veran has been providing an update this evening on the government’s coronavirus strategy and has specifically addres... Evening Update Thursday 17 September 2020 Read More

17/09/2020